Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin

Catella-Lawson, Francesca, Reilly, Muredach P., Kapoor, Shiv C., Cucchiara, Andrew J., DeMarco, Susan, Tournier, Barbara, Vyas, Sachin N., FitzGerald, Garret A.·2001·New England Journal of Medicine

DOI 10.1056/nejmoa003199

Cited by (1,000)

Items 401–500 of 1,000

Mitigating the Cardiovascular and Renal Effects of NSAIDs: Table 1
Rodolfo Curiel, James David Katz · 2013 · Pain Medicine
Recent advance in antiplatelet therapy: The mechanisms, evidence and approach to the problems
Hisanori Horiuchi · 2006 · Annals of Medicine
Coxibs: Pharmacology, Toxicity and Efficacy in Cancer Clinical Trials
Luis Alberto García Rodríguez, Lucía Cea Soriano, Stefania Tacconelli, Paola Patrignani · 2012 · Recent results in cancer research/Recent Results in Cancer Research
Essential Polyunsaturated Fatty Acids, Inflammation, Atherosclerosis and Cardiovascular Diseases
Michel de Lorgeril · 2007 · Sub-cellular biochemistry/Subcellular biochemistry
Aspirin attenuates vinorelbine-induced endothelial inflammation via modulating SIRT1/AMPK axis
Kun‐Ling Tsai, Po‐Hsun Huang, Chung-Lan Kao, Hsin‐Bang Leu, Yung‐Hsin Cheng, Yi‐Wen Liao, Yi-Ping Yang, Yueh Chien, Chien‐Ying Wang, Chen-Yuan Hsiao et al. · 2013 · Biochemical Pharmacology
Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction
Dong Oh Kang, Hyonggin An, Geun U. Park, Yunjin Yum, Eun‐Jin Park, Yoonjee Park, Won Young Jang, Woohyeun Kim, Jah Yeon Choi, Seung‐Young Roh et al. · 2020 · Journal of the American College of Cardiology
Antiplatelet drug response variability and the role of platelet function testing: A practical guide for interventional cardiologists
Dominick Joseph Angiolillo, Siva Suryadevara, Piera Capranzano, Martin Z Zenni, Luis A. Guzmán, Theodore A. Bass · 2008 · Catheterization and Cardiovascular Interventions
Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-tereated healthy adult volunteers
Byron Cryer, Roger G. Berlin, Stephen A. Cooper, Ching Hsu, Suman Wason · 2005 · Clinical Therapeutics
Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
Thana Turajane, Rungsee Wongbunnak, Tanisa Patcharatrakul, Kaseam Ratansumawong, Yutana Poigampetch, Thawee Songpatanasilp · 2009 · PubMed
Pharmacotherapeutic approaches to the prevention of Alzheimer's disease
John B. Standridge · 2004 · The American Journal of Geriatric Pharmacotherapy
Coxibs, non‐steroidal anti‐inflammatory drugs and cardiovascular risk
Matthias Hermann, Frank Thomas Ruschitzka · 2006 · Internal Medicine Journal
Drug Insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk—where are we now?
Gary Spektor, Valentı́n Fuster · 2005 · Nature Clinical Practice Cardiovascular Medicine
Antiplatelet Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes
Steven P. Schulman · 2004 · JAMA
Aspirin and aspirin resistance in coronary artery disease
Charalampos Kasmeridis, Stavros Z. Apostolakis, Gregory Y.H. Lip · 2013 · Current Opinion in Pharmacology
Prevention of upper gastrointestinal haemorrhage: current controversies and clinical guidance
Johanne Brooks, Richard C. Warburton, Ian Beales · 2013 · Therapeutic Advances in Chronic Disease
Platelet Function Testing in Contemporary Clinical and Interventional Practice
Francesco Franchi, Fabiana Rollini, Jung Rae Cho, Elisabetta Ferrante, Dominick Joseph Angiolillo · 2014 · Current Treatment Options in Cardiovascular Medicine
Efficiency of the cross‐over design: an empirical estimation
Raquel García‐Esteban, Marta Benet, Catalina Arnau, Erik Cobo · 2004 · Statistics in Medicine
Antiplatelet drug resistance: Molecular insights and clinical implications
Christopher Nicholas Floyd, Albert Ferro · 2015 · Prostaglandins & Other Lipid Mediators
Initiation and adherence to secondary prevention pharmacotherapy after myocardial infarction in patients with rheumatoid arthritis: a nationwide cohort study
Jesper Lindhardsen, Ole Ahlehoff, Gunnar Gislason, Ole Rintek Madsen, Jonas Bjerring Olesen, Christian Tobias Torp-Pedersen, Peter Riis Hansen · 2012 · Annals of the Rheumatic Diseases
Not all (N)SAID and done: Effects of nonsteroidal anti‐inflammatory drugs and paracetamol intake on platelets
Ben Driver, Denese C. Marks, Dianne E. van der Wal · 2019 · Research and Practice in Thrombosis and Haemostasis
Diabetes, vascular complications and antiplatelet therapy: open problems
Anna Maria Cerbone, N. Macarone-Palmieri, Gennaro Saldalamacchia, Antonio Coppola, Giovanni Di Minno, Angela Albarosa Rivellese · 2008 · Acta Diabetologica
Aspirin Resistance: An Evaluation of Current Evidence and Measurement Methods
Christopher P. Martin, Robert L. Talbert · 2005 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
Minimizing risks of NSAIDs: cardiovascular, gastrointestinal and renal
Neal M. Davies, Jonathon K Reynolds, Megan R. Undeberg, Brian J. Gates, Yusuke Ohgami, Karina R. Vega‐Villa · 2006 · Expert Review of Neurotherapeutics
Clinical Uses of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Potential Benefits of NSAIDs Modified-Release Preparations
Maja A. Tomic´, Ana M. Micov, Uroš B. Pecikoza, Radica M. Stepanović-Petrović · 2017 · Elsevier eBooks
Efficacy and Safety of Ibuprofen in Infants Aged Between 3 and 6 Months
Victoria C. Ziesenitz, Andreas W Zutter, Thomas O. Erb, John N. van den Anker · 2017 · Pediatric Drugs
Selection of analgesics for the management of acute and postoperative dental pain: a mini-review
Sung‐Jin Kim, Jeong Taeg Seo · 2020 · Journal of Periodontal & Implant Science
Cyclooxygenase-2 Inhibitors, Nonsteroidal Anti-inflammatory Drugs, and Cardiovascular Risk
Orly Vardeny, Scott David Solomon · 2008 · Cardiology Clinics
Cardiovascular Effects of Noncardiovascular Drugs
Satish R. Raj, C. Michael Stein, Pablo J. Saavedra, Dan M. Roden · 2009 · Circulation
The ever growing story of cyclo-oxygenase inhibition
Luis Alberto García Rodríguez, Paola Patrignani · 2006 · The Lancet
Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: Benefit or risk?
Massimo Leggio, Maria Grazia Bendini, Elisa Caldarone, M. Lombardi, P. Severi, Stefania D’Emidio, D.C. Stavri, Massimo Armeni, Veronica Bravi, Antonio Mazza · 2017 · Diabetes & Metabolism
Cardiovascular risks associated with low-dose ibuprofen and diclofenac as used OTC
Nicholas D Moore, Francesco Salvo, Mai Duong, Patrick Blin, Antoine Pariente · 2013 · Expert Opinion on Drug Safety
Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration
Sofie Sommer Hedegaard, Anne‐Mette Hvas, Erik Lerkevang Grove, Jens Christian Refsgaard, Bianca Rocca, Giovanni Davı̀, Steen Dalby Kristensen · 2009 · Thrombosis Research
Gastroduodenal toxicity of low-dose acetylsalicylic acid: a comparison with non-steroidal anti-inflammatory drugs
Neville D. Yeomans, Christopher J. Hawkey, Wayne Brailsford, Jorgen Næsdal · 2009 · Current Medical Research and Opinion
Advances in monitoring of aspirin therapy
Marie Lordkipanidzé · 2012 · Platelets
Aspirin Resistance
Khaled Mansour, Ali T. Taher, Khaled M. Musallam, Samir Alam · 2009 · Advances in Hematology
An examination of the bleeding complications associated with herbal supplements, antiplatelet and anticoagulant medications.
Ann Eshenaur Spolarich, Lynn Andrews · 2007 · PubMed
Elevation of cardiovascular risk by non-steroidal anti-inflammatory drugs
Asif Anwar, Imran John Anwar, Patrice Delafontaine · 2015 · Trends in Cardiovascular Medicine
Aspirin and Other COX-1 Inhibitors
Carlo Patrono, Bianca Rocca · 2012 · Handbook of experimental pharmacology
First-generation agents: aspirin, heparin and coumarins
Richard L. Mueller · 2004 · Best Practice & Research Clinical Haematology
Analgesic agents without gastric damage: Design and synthesis of structurally simple benzenesulfonanilide-type cyclooxygenase-1-selective inhibitors
Xiaoxia Zheng, Hiroyuki Oda, Kayo Takamatsu-Yukawa, Yukio Sugimoto, Akihiro Tai, Eiichi Akaho, Hamed Ismail Ali, Toshiyuki Oshiki, Hiroki Kakuta, Kenji Sasaki · 2006 · Bioorganic & Medicinal Chemistry
Acetylsalicylic Acid and Acetaminophen to Combat Elevated Body Temperature in Acute Ischemic Stroke
Geert Sulter, Jan Willem J. Elting, Natasha M. Maurits, Gert Jan Luijckx, Jacques De Keyser · 2003 · Cerebrovascular Diseases
Co-Administration of Nitric Oxide-Aspirin (NCX-4016) and Aspirin Prevents Platelet and Monocyte Activation and Protects Against Gastric Damage Induced by Aspirin in Humans
Stefano Fiorucci, Andrea Mencarelli, Alessandra Meneguzzi, Alessandro Lechi, Barbara Renga, Piero Del Soldato, Antonio Morelli, Pietro Minuz · 2004 · Journal of the American College of Cardiology
COX-2-selective inhibitors in the treatment of arthritis.
Thomas J. Schnitzer, M. Hochberg · 2002 · Cleveland Clinic Journal of Medicine
Genetic and Acquired Determinants of Individual Variability of Response to Antiplatelet Drugs
Andrew I. Schafer · 2003 · Circulation
Cyclooxygenase Inhibitors: Instrumental Drugs to Understand Cardiovascular Homeostasis and Arterial Thrombosis
Natalia Bunimov, Odette Laneuville · 2008 · Cardiovascular & Haematological Disorders - Drug Targets
Prevention and Treatment of NSAID Gastropathy
Carla J. Gargallo, Carlos Sostres, Ángel Lanas · 2014 · Current Treatment Options in Gastroenterology
A narrative review of the cardiovascular risks associated with concomitant aspirin and NSAID use
Paul Alfred Gurbel, Udaya S. Tantry, Steven M. Weisman · 2018 · Journal of Thrombosis and Thrombolysis
Recommendations from the ICM-VTE: General
The ICM-VTE General Delegates · 2022 · Journal of Bone and Joint Surgery
Analysis of platelet α2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy
Katarína Vargová, Ádám László, Tamás Masszi, Gábor Kerecsen, István Préda, Róbert Gábor Kiss, Bernát János Béres, Emese Tóth-Zsámboki · 2008 · Thrombosis and Haemostasis
Diabetes and Platelet Response to Low-dose Aspirin
Mohammed E. Al‐Sofiani, Lisa R. Yanek, Nauder R. Faraday, Brian G. Kral, Rasika A. Mathias, Lewis C. Becker, Diane M. Becker, Dhananjay M. Vaidya, Rita Rastogi Kalyani · 2018 · The Journal of Clinical Endocrinology & Metabolism
Aspirin, stroke and drug-drug interactions
Nicholas W. Russo, Giovanna Petrucci, Bianca Rocca · 2016 · Vascular Pharmacology
The Emergent Phenomenon of Aspirin Resistance: Insights from Genetic Association Studies
Márcia Ferreira, Margarida Freitas-Silva, Joana Assis, Ricardo Pinto, José Pedro L. Nunes, Rui Medeiros · 2020 · Pharmacogenomics
The Effects of EPA, DHA, and Aspirin Ingestion on Plasma Lysophospholipids and Autotaxin
Robert Block, Richard Duff, Peter Lawrence, Lisa Kakinami, James Thomas Brenna, Gregory C. Shearer, Nida Meednu, Shaker A. Mousa, Alan E. Friedman, William Stephen Harris et al. · 2010 · Prostaglandins Leukotrienes and Essential Fatty Acids
Variable Platelet Response to Aspirin in Patients with Ischemic Stroke
Thomas Hohlfeld, Artur‐Aron Weber, Ulrich Junghans, Marc Schumacher, Marc Boucher, Karsten Schrör, Mario Siebler · 2007 · Cerebrovascular Diseases
Aspirin Resistance
Kenneth A. Schwartz · 2011 · The Neurohospitalist
Signaling Pathways Involved in Sphingosine Kinase Activation and Sphingosine-1-Phosphate Release in Rat Myometrium in Late Pregnancy: Role in the Induction of Cyclooxygenase 2
Martin Serrano-Sanchez, Zahra Tanfin, Denis Leiber · 2008 · Endocrinology
Paracetamol in the Treatment of Osteoarthritis Pain
Kenneth D. Brandt · 2003 · Drugs
Effects of Cyclooxygenases Inhibitors on Vasoactive Prostanoids and Thrombin Generation at the Site of Microvascular Injury in Healthy Men
E. Tuleja, Filip Mejza, Adam Ćmiel, Andrzej Szczeklik · 2003 · Arteriosclerosis Thrombosis and Vascular Biology
Antithrombotic therapy in children
Elizabeth A. Chalmers, Mariana M. Bonduel · 2005 · Progress in Pediatric Cardiology
Gastrointestinal diseases in the elderly
Peter R. Holt · 2003 · Current Opinion in Clinical Nutrition & Metabolic Care
Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects
Naveen Ahuja, Àmarjit Singh, Bhupinder Singh · 2003 · Journal of Pharmacy and Pharmacology
A brief review on high on-aspirin residual platelet reactivity
Alf‐Åge R. Pettersen, Harald Arnesen, Ingebjørg Seljeflot · 2015 · Vascular Pharmacology
Significance of urinary 11-dehydro-thromboxane B2 in age-related diseases: Focus on atherothrombosis
Paola Simeone, Andrea Boccatonda, Rossella Liani, Francesca Santilli · 2018 · Ageing Research Reviews
Prediction of time-dependent interaction of aspirin with ibuprofen using a pharmacokinetic/pharmacodynamic model
Keisuke Awa, Hiroki Satoh, Satoko Hori, Yasufumi Sawada · 2011 · Journal of Clinical Pharmacy and Therapeutics
Sulfasalazine and its metabolites inhibit platelet function in patients with inflammatory arthritis
Paul MacMullan, Anne M. Madigan, Paul Nevin, Aaron J. Peace, Ahmed B. M. Alagha, Kevin B. Nolan, Géraldine McCarthy, Dermot J. Kenny · 2014 · Clinical Rheumatology
Pharmacogenetics of the Antiplatelet Effect of Aspirin
Morten Würtz, Steen Dalby Kristensen, Anne‐Mette Hvas, Erik Lerkevang Grove · 2012 · Current Pharmaceutical Design
Etoricoxib for arthritis and pain management.
Peter Brooks, Paul A. Kubler · 2006 · PubMed Central
Antiplatelet Activity of J78 (2-Chloro-3-[2′-bromo, 4′-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an Antithrombotic Agent, Is Mediated by Thromboxane (TX) A2 Receptor Blockade with TXA2 Synthase Inhibition and Suppression of Cytosolic Ca2+ Mobilization
Yong-Ri Jin, Mi‐Ra Cho, Chung‐Kyu Ryu, Jin‐Ho Chung, Dong-Yeon Yuk, Jin Tae Hong, Kyung-Sup Lee, Jung‐Jin Lee, Mi-Yea Lee, Yong Lim et al. · 2004 · Journal of Pharmacology and Experimental Therapeutics
Hypothesis formulation from subgroup analyses: Nonadherence or nonsteroidal anti-inflammatory drug use explains the lack of clinical benefit of aspirin on first myocardial infarction attributed to “aspirin resistance”
Charles H. Hennekens, Wendy R. Schneider, Patricia R. Hebert, Udaya S. Tantry, Paul Alfred Gurbel · 2010 · American Heart Journal
For Discussion NSAIDs: gastroprotection or selective COX-2 inhibitor?
Andrew R. Dickman, John Ellershaw · 2004 · Palliative Medicine
Documento de Consenso de Expertos sobre el uso de agentes antiplaquetarios
Carlo Patrono, F Bachmann, Colin Baigent, Christopher Bode (Alemania), Raffaele De Caterina, B Charbonnier, Desmond Fitzgerald, Jack Hirsh, Steen Husted, J Kvasnička et al. · 2004 · Revista Española de Cardiología
Recent developments in cyclooxygenase inhibition
Lawrence J. Marnett · 2002 · Prostaglandins & Other Lipid Mediators
Failure of Aspirin to Prevent Atherothrombosis
John W. Eikelboom, Graeme J. Hankey · 2004 · American Journal of Cardiovascular Drugs
Antiplatelet Agents for the Prevention of Cardiovascular Disease in Diabetes Mellitus
John A. Colwell · 2004 · American Journal of Cardiovascular Drugs
Over-the-Counter Pain Reliever and Aspirin Use Within a Sample of Long-term Cyclooxygenase 2 Users
Emily R. Cox, Mark E. Frisse, Andrew Behm, Kathleen A. Fairman · 2004 · Archives of Internal Medicine
Cardiorenal Safety of OTC Analgesics
White, William B., Kloner, Robert A., Angiolillo, Dominick J., Davidson, Michael H. · 2018 · Journal of Cardiovascular Pharmacology and Therapeutics
Controversies in Oral Antiplatelet Therapy in Patients Undergoing Aortocoronary Bypass Surgery
Elisabeth Mahla, Helfried Metzler, Udaya S. Tantry, Paul Alfred Gurbel · 2010 · The Annals of Thoracic Surgery
Prevention of dipyrone (metamizole) induced inhibition of aspirin antiplatelet effects
Stefan E. Richter, Karsten Schrör, Tienush Rassaf, Marc W. Merx, Malte Kelm, Thomas Hohlfeld, Tobias Zeus, Amin Polzin · 2015 · Thrombosis and Haemostasis
Nonsteroidal Anti-inflammatory Drugs in the Treatment of Pericarditis
Branislav Schifferdecker, David H. Spodick · 2003 · Cardiology in Review
Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease
Maria Gina Sciulli, Giulia Renda, Marta L. Capone, Stefania Tacconelli, Emanuela Ricciotti, Stefano Manarini, Virgilio Evangelista, Antonio G. Rebuzzi, Paola Patrignani · 2006 · Clinical Pharmacology & Therapeutics
Nonsteroidal Anti-inflammatory Drug Use Is a Significant Cause of Peptic Ulcer Disease in a Tertiary Hospital in Singapore: A Prospective Study
Tze-Zen Ong, C J Hawkey, Khek Yu Ho · 2006 · Journal of Clinical Gastroenterology
Mildly elevated unconjugated bilirubin is associated with reduced platelet activation-related thrombogenesis and inflammation in Gilbert’s syndrome
Avinash Kundur, Abishek Bommannan Santhakumar, Andrew Cameron Bulmer, Indu Singh · 2017 · Platelets
Rofecoxib does not compromise platelet aggregation during anesthesia and surgery
David G. Silverman, Thomas M. Halaszynski, Raymond S. Sinatra, Martha A. Luther, Christine S. Binder · 2003 · Canadian Journal of Anesthesia/Journal canadien d anesthésie
Adverse Drug Reactions: History, Terminology, Classification, Causality, Frequency, Preventability
Jeffrey K Aronson · 2011 · Wiley eBooks
Potential for Drug–Drug Interactions in Patients Taking Analgesics for Mild-to-Moderate Pain and Low-Dose Aspirin for Cardioprotection
Gaziano, J. Michael, Gibson, C. Michael · 2006 · The American Journal of Cardiology
O uso indiscriminado dos Anti-Inflamatórios Não Esteroidais (AINES)
Alline Corrêia Sandoval, Dione Rodrigues Fernandes, Ederson Aparecido da Silva, André Tomaz Terra Júnior · 2017 · Revista Científica FAEMA
Antiplatelet Agents for Stroke Prevention
Samuel Yip, Oscar Benavente · 2011 · Neurotherapeutics
Using pharmacokinetic principles to optimize pain therapy
Kay Brune, Bertold Renner, Burkhard Hinz · 2010 · Nature Reviews Rheumatology
Cardiovascular effects of cyclooxygenase-2 inhibitors
James M. Brophy · 2008 · Current Opinion in Internal Medicine
Clinical importance of antiplatelet drugs in cardiovascular diseases
Judit Papp, Peter Kenyeres, Kálmán Tóth · 2013 · Clinical Hemorheology and Microcirculation
P of platelet to Aspirin
Nauder R. Faraday, Diane M. Becker, Lewis C. Becker · 2007 · Pharmacogenomics
Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors
Olivier Barthélémy, Tobias Limbourg, Jean‐Philippe Collet, Farzin Beygui, Johanne Silvain, Anne Bellemain-Appaix, Guillaume Cayla, Thomas Chastre, Iris Baumgärtner, Joachim Röther et al. · 2011 · International Journal of Cardiology
Antiplatelet therapies and the role of antiplatelet resistance in acute coronary syndrome
Allison G. Dupont, Don A. Gabriel, Mauricio G. Cohen · 2009 · Thrombosis Research
Self-Medication Practices of Spanish-Speaking Older Adults in Hartford, Connecticut
Patricia J. Neafsey, Olga F. Jarrin, Surheil Luciano, Maren J. Coffman · 2007 · Hispanic Health Care International
Impact of non-steroidal anti-inflammatory drugs on cardiovascular risk: Is it the same in osteoarthritis and rheumatoid arthritis?
Vasiliki-Kalliopi Bournia, George D. Kitas, Athanase D. Protogerou, Petros Paul Sfikakis · 2016 · Modern Rheumatology
The future of traditional nonsteroidal antiinflammatory drugs and cyclooxygenase-2 inhibitors in the treatment of inflammation and pain.
Maria Gina Sciulli, Marta L. Capone, Stefania Tacconelli, Paola Patrignani · 2005 · PubMed
Is there an Interaction between the Cardiovascular Protective Effects of Low‐Dose Aspirin and Ibuprofen?
Thomas MacLennan MacDonald, Li Wei · 2006 · Basic & Clinical Pharmacology & Toxicology
Direct and Irreversible Inhibition of Cyclooxygenase-1 by Nitroaspirin (NCX 4016)
Teresa Corazzi, Mario Leone, Raffaella Maucci, Lanfranco Corazzi, Paolo Gresele · 2005 · Journal of Pharmacology and Experimental Therapeutics
Clinical Implications of Nonopioid Analgesia for Relief of Mild-to-Moderate Pain in Patients with or at Risk for Cardiovascular Disease
Whelton, Andrew · 2006 · The American Journal of Cardiology
Recent advances in the role of neutrophils and neutrophil extracellular traps in acute pancreatitis
Hassan Mubarak Ishqi, Misha Ali, Rajinder Kumar Dawra · 2023 · Clinical and Experimental Medicine